They have signed long term agreements with DaVita and Fresenuis which in effect cuts Affy out of the game. Come to find out these Centers had decided to "Pause" the use of Omontys prior to the recall, and to not expand the use in the future, which meant no income for Affy.
So you do 10 years of research with a partner...get it FDA approved..and than learn that all your efforts have been useless and for nothing because the only competitor in this market controls the outlets (or whats that called) yes, depressing indeed.
enhance your calm bill. That is an old filing and also keep in mind that AMGEN was recently sued for such practices and settled for 24.9 million dollars with the SEC to bury those allegations. So Fresenuis and DaVita have contracts, there are dozens of other companies who also run dialysis center. Stop freaking out as you approach the end of the race.